Screener
EBITDA at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
FAQ
- What is Ironwood Pharmaceuticals's EBITDA?
- Ironwood Pharmaceuticals (IRWD) reported EBITDA of $79.76M in Q2 2026.
- How has Ironwood Pharmaceuticals's EBITDA changed year-over-year?
- Ironwood Pharmaceuticals's EBITDA increased by 74.2% year-over-year, from $45.79M to $79.76M.
- What is the long-term trend for Ironwood Pharmaceuticals's EBITDA?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's EBITDA has grown at a -19.0% compound annual growth rate (CAGR), from $233.76M to $100.38M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Ironwood Pharmaceuticals's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude